Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP340744.RABYe_Ub-P2XaRIfn7ZXPfDMF9Epe5wDlA8-tP33gMbUs130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340744.RABYe_Ub-P2XaRIfn7ZXPfDMF9Epe5wDlA8-tP33gMbUs130_provenance.
• NP898312.RABb8dW1p-E7HIQSg5ZdImWk_z2y3L9KAV1RA3zjpu0Jc130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898312.RABb8dW1p-E7HIQSg5ZdImWk_z2y3L9KAV1RA3zjpu0Jc130_provenance.
• NP641725.RAj74CBUk4fTsW_cP_iLROpLcGIHY8X7Ai5l1gAEr2CtE130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641725.RAj74CBUk4fTsW_cP_iLROpLcGIHY8X7Ai5l1gAEr2CtE130_provenance.
• NP620797.RA-NQmT-0F9nuethkK8xhO9VVlPlltM8Yf_8US7MCcnbU130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620797.RA-NQmT-0F9nuethkK8xhO9VVlPlltM8Yf_8US7MCcnbU130_provenance.
• NP648575.RAR95GmGm7xMDb__WsM-TJFPqhN2qKqGCyQFXHedwQPUI130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648575.RAR95GmGm7xMDb__WsM-TJFPqhN2qKqGCyQFXHedwQPUI130_provenance.
• NP502942.RA8opoyvnY7VRT9vJkzF73p_zgBIGI-IzqMxknprt2_Zw130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502942.RA8opoyvnY7VRT9vJkzF73p_zgBIGI-IzqMxknprt2_Zw130_provenance.
• NP727004.RA8MkPARqvg669achB4i_8kU-cdDtX3vooZnnsnKwpiOk130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727004.RA8MkPARqvg669achB4i_8kU-cdDtX3vooZnnsnKwpiOk130_provenance.
• assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP419643.RASqz6An9mqSB4XCoj5zgxcUe8Lww1lLcTHZrieMjdp1Y130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419643.RASqz6An9mqSB4XCoj5zgxcUe8Lww1lLcTHZrieMjdp1Y130_provenance.
• NP419646.RAeHaNEBhySCBQ_Uo8uIpBQgN-kbZWMzTveLgqqB-U508130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419646.RAeHaNEBhySCBQ_Uo8uIpBQgN-kbZWMzTveLgqqB-U508130_provenance.
• NP792084.RAMYXQgFUVVQzEundU_-63nwH0LG03WnhEtz9MupCvnrQ130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792084.RAMYXQgFUVVQzEundU_-63nwH0LG03WnhEtz9MupCvnrQ130_provenance.
• NP419645.RAES-iCLkOyPCIRz7eBx3Q9kev1BU-X2NuLDOsrqO-OWY130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419645.RAES-iCLkOyPCIRz7eBx3Q9kev1BU-X2NuLDOsrqO-OWY130_provenance.
• NP791943.RA0LgtOSwl-Rf2bnPBvAPyci4InaD8bt_qTJ-ECb3hPJI130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791943.RA0LgtOSwl-Rf2bnPBvAPyci4InaD8bt_qTJ-ECb3hPJI130_provenance.
• NP419652.RA1kqK1xKGVLYaSFLxCZEG2Wq7BDInAfAnzbjgz6hBzUM130_assertion description "[We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419652.RA1kqK1xKGVLYaSFLxCZEG2Wq7BDInAfAnzbjgz6hBzUM130_provenance.